OYAK Çimento Fabrikalari A.S. (IST:OYAKC)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions TRY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	115,999	116,679	64,311	24,379	9,162	10,183
Market Cap Growth	35.55%	81.43%	163.80%	166.08%	-10.02%	1470.52%
Enterprise Value	107,324	108,631	60,624	24,083	9,284	10,615
Last Close Price	23.86	24.00	14.22	5.39	2.03	2.25
PE Ratio	17.15	16.28	5.48	2.76	12.64	28.41
Forward PE	-	13.44	13.44	13.44	13.44	13.44
PS Ratio	2.69	2.63	1.45	0.93	1.96	3.47
PB Ratio	2.24	2.56	1.67	1.31	3.08	4.46
P/TBV Ratio	2.56	2.90	1.93	1.61	3.16	4.63
P/FCF Ratio	-	73.43	11.84	15.48	28.45	43.48
P/OCF Ratio	14.49	12.41	8.09	8.00	13.89	19.45
EV/Sales Ratio	2.49	2.44	1.37	0.92	1.98	3.62
EV/EBITDA Ratio	9.22	8.37	4.49	3.59	9.19	21.12
EV/EBIT Ratio	12.06	10.26	5.21	4.44	11.08	30.20
EV/FCF Ratio	-153.08	68.36	11.16	15.29	28.83	45.33
Debt / Equity Ratio	0.07	0.01	0.06	0.16	0.16	0.37
Debt / EBITDA Ratio	0.33	0.02	0.18	0.44	0.45	1.63
Debt / FCF Ratio	-	0.14	0.45	1.90	1.45	3.56
Asset Turnover	0.75	0.83	1.02	1.30	1.06	0.80
Inventory Turnover	4.82	5.00	6.12	8.26	5.81	6.14
Quick Ratio	1.43	1.62	1.55	1.05	1.26	0.94
Current Ratio	1.95	2.36	2.22	1.82	1.88	1.23
Return on Equity (ROE)	15.38%	17.04%	40.61%	82.34%	27.57%	16.70%
Return on Assets (ROA)	9.60%	12.32%	16.76%	16.70%	11.84%	5.99%
Return on Capital (ROIC)	11.96%	15.26%	23.28%	27.11%	15.96%	7.40%
Return on Capital Employed (ROCE)	16.00%	22.60%	28.10%	19.90%	24.00%	14.50%
Earnings Yield	5.83%	6.14%	18.25%	36.19%	7.92%	3.52%
FCF Yield	-0.60%	1.36%	8.45%	6.46%	3.52%	2.30%
Dividend Yield	4.08%	4.17%	-	-	-	-
Buyback Yield / Dilution	3.36%	-	0.00%	-7.48%	-	-47.64%
Total Shareholder Return	7.45%	4.17%	-	-7.48%	-	-47.64%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.